Binder Gwendolyn

President, Science & Tech.Cabaletta Bio, Inc. (CABA) · full profile →Form 4 · filed May 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 19, 2025Disposed to issuer(D)67K$00
May 19, 2025Grant(A)67K$067K
May 19, 2025Disposed to issuer(D)30K$00
May 19, 2025Grant(A)30K$030K
May 19, 2025Disposed to issuer(D)125K$00
May 19, 2025Grant(A)125K$0125K
May 19, 2025Disposed to issuer(D)160K$00
May 19, 2025Grant(A)160K$0160K
May 19, 2025Disposed to issuer(D)176K$00
May 19, 2025Grant(A)176K$0176K
May 19, 2025Disposed to issuer(D)130K$00
May 19, 2025Grant(A)130K$0130K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-074816) within minutes of acceptance. Every field above traces to the original document. Verify it directly: